KRT6A, an essential cytoskeletal component in mammalian cells, mediates alterations in tumor-associated macrophage (TAMs) subtypes through different proteins and pathways in PC and is considered a new potential therapeutic target for TAMs in PC immunotherapy48. The gene discussed is KRT6A; the disease is neoplasm.